Insider trades
Viking Global Opportunities GP, 10% Owner of Inhibrx Biosciences INBX, has filed 4 purchases and 18 sales on the open market. Over the past 12 months that comes to a net sale of $11.3M. The latest trade was on 25/10/07.
Viking Global Opportunities GP
10% Owner
- Company
- Inhibrx Biosciences INBX
- First filing
- 23/05/11
- Trades
- 43 trades
- Buys / sales
- 4 / 18
- 12-month net buying
- −$11.3M
- Last trade
- 25/10/07
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
INBX | Open-market sale | 25/10/07 | 25/10/09 | 350,000 sh3 trades | $32.25avg. | $11,287,500 | −77.3% |
BridgeBio PharmaBBIO | Open-market sale | 25/06/27 | 25/07/01 | 3,500,000 sh | $44.00 | $154,000,000 | −15.9% |
BridgeBio PharmaBBIO | Open-market sale | 25/01/31 | 25/01/31 | 3,065,616 sh | $34.90 | $106,989,998.4 | −12.2% |
APG | Open-market sale | 24/06/17 | 24/06/18 | 1,951,782 sh2 trades | $38.15avg. | $74,460,483.3 | −100.0% |
APG | Open-market sale | 24/03/05 | 24/03/07 | 3,038,617 sh2 trades | $34.25avg. | $104,072,632.25 | −98.7% |
| Open-market sale | 24/01/04 | 24/01/05 | 540,000 sh | $19.53 | $10,546,200 | −11.3% | |
APG | Open-market sale | 24/01/02 | 24/01/04 | 6,500,000 sh3 trades | $31.30avg. | $203,450,000 | −99.7% |
| Open-market buy | 23/09/19 | 23/09/21 | 1,388,889 sh2 trades | $18.00avg. | $25,000,002 | +391.6% | |
| Open-market buy | 23/08/28 | 23/08/30 | 511,627 sh | $19.35 | $9,899,982.45 | No record | |
BridgeBio PharmaBBIO | Open-market sale | 23/07/18 | 23/07/19 | 1,500,000 sh | $35.00 | $52,500,000 | −5.6% |
ROIV | Open-market sale | 23/06/22 | 23/06/26 | 13,000,000 sh4 trades | $9.90avg. | $128,700,000 | −50.2% |
| Open-market buy | 23/05/09 | 23/05/11 | 850,000 sh | $16.00 | $13,600,000 | +21.6% |
